We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Direct Purchasers Criticize Wyeth’s Immunity Claim in Brand-Generic Agreement Case
Direct Purchasers Criticize Wyeth’s Immunity Claim in Brand-Generic Agreement Case
Pfizer-subsidiary Wyeth is claiming immunity in a long-running antitrust lawsuit involving an alleged pay-for-delay generics scheme with Teva, but a group of pharmaceutical purchasers aren’t buying the argument.